Antios Therapeutics Funding: $171M Raised, Series B (2021)
Antios Therapeutics is based in Doylestown, PA. It has raised $171M in total funding. Latest round: Series B.
Antios Therapeutics funding overview
Antios Therapeutics is based in Doylestown, PA. Antios Therapeutics has raised $171M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Antios Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include GordonMD Global Investments, EPIQ Capital Group, Arbutus Biopharma, Assembly Biosciences. 4 distinct backers are named across the disclosed rounds.
Antios Therapeutics at a glance
Total raised
$171M
Latest round
Series B
Latest round date
January 2021
Headquarters
Doylestown, PA
Notable investors
GordonMD Global Investments, EPIQ Capital Group, Arbutus Biopharma, Assembly Biosciences
Frequently asked about Antios Therapeutics funding
How much has Antios Therapeutics raised?
Antios Therapeutics has raised $171M in total disclosed funding across the rounds on record.
Who has invested in Antios Therapeutics?
GordonMD Global Investments, EPIQ Capital Group, Arbutus Biopharma, Assembly Biosciences are named among the investors backing Antios Therapeutics.
What was the latest Antios Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is Antios Therapeutics based?
Antios Therapeutics is based in Doylestown, PA.
When did Antios Therapeutics last raise?
The last disclosed Antios Therapeutics round closed in January 2021 at Series B.
Round data for Antios Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Doylestown and backer lists below.
